230
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Repetitive drug-induced liver injury with kedaling tablets

Pages 853-854 | Received 25 Dec 2020, Accepted 21 Jan 2021, Published online: 12 Feb 2021

References

  • Liu C, Fan H, Li Y, et al. Research advances on hepatotoxicity of herbal medicines in China. Biomed Res Int. 2016; 2016:7150391–71503106.
  • Wan L, Zhao Y, Zhang Q, et al. Alkaloid extract of Corydalis yanhusuo inhibits angiogenesis via targeting vascular endothelial growth factor receptor signaling. BMC Complement Altern Med. 2019;19(1):359–372.
  • Norman BH. Drug Induced Liver Injury (DILI). Mechanisms and medicinal chemistry avoidance/mitigation strategies. J Med Chem. 2020;63(20):11397–11419.
  • Huang Y, Huang H, Wang S, et al. Dehydrocorydaline inhibits the tumorigenesis of breast cancer MDA‑MB‑231 cells. Mol Med Rep. 2020;22(1):43–50.
  • Xia XH, He JC, Liu B, et al. Targeting ERα degradation by L-tetrahydropalmatine provides a novel strategy for breast cancer treatment. Int J Biol Sci. 2020;16(12):2192–2204.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.